Epigenetic Regulation of Cell and Tissue Aging
Epigenetic Regulation of Cell and Tissue Aging
批准号:
7917307
负责人:
Nikolai A. Timchenko
金额:
$30.53万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-08-31
关键词:
AcidsAgeAgingAnimalsAppearanceBiological AssayBiological MarkersCDKN2A geneCell AgingCell Culture TechniquesCellsCharacteristicsChromatinChromatin Remodeling FactorCo-ImmunoprecipitationsComplexCyclin EDNADNA DamageDNA Double Strand BreakDNA lesionDataDeacetylaseDepositionDominant-Negative MutationDouble Strand Break RepairDown-RegulationEctopic ExpressionEngineeringEpigenetic ProcessEuchromatinEventExclusionFatty LiverFractionationFrozen SectionsGenomeGrowthHDAC1 geneHeterochromatinHigh Pressure Liquid ChromatographyHigher Order Chromatin StructureHistone CodeHistone DeacetylaseHistone H3Histone H4HistonesHomologous GeneHumanImmunofluorescence ImmunologicIncidenceInfectionInsulinInterventionLabelLaboratoriesLeadLinkLiverLongevityLysineMaintenanceMalignant - descriptorMass Spectrum AnalysisMeasuresMelanocytic nevusMelanoma CellMethodsMethylationModelingModificationMolecularMolecular ChaperonesMorphologyMusNuclearNuclear PleomorphismOncogenesOncogenicPathologyPathway interactionsPhenotypePhosphorylationPlayPopulationPrincipal InvestigatorProcessProliferatingProteinsReadingRecruitment ActivityRegulationResearch PersonnelRoleSignal PathwaySignal TransductionSmall Interfering RNASomatomedinsStressStructureSumSystemTP53 geneTechnologyTestingTetanus Helper PeptideTissuesVariantViralWestern BlottingWorkYeastsbasebeta-Galactosidasebrahmabrahma proteinchromatin modificationchromatin remodelinghistone acetyltransferasehistone modificationin vivomelanocyteoverexpressionpreventprogramsprotein functionregenerativerepairedresponsesenescencetelomeretranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Normal human cells respond to potentially oncogenic events such as short telomeres, DNA damage and
activating oncogenes by irreversibly arresting growth with a characteristic phenotype termed cellular
senescence. This process, first identified in cell culture, has been recently confirmed in vivo as a critical
mechanism that curtails the malignant progression of human tumors. The RB/p16INK4a, but not p53,
pathway regulates the senescence of human melanocytes in culture and melanocytic nevi in vivo. This
senescence response is likely due to chromatin modifications because RB complexes from senescent
melanocytes contain increased levels of histone deacetylase activity and tethered HDAC1. We have found
that expression of moderate levels of HDAC1 drives a sequential and cooperative activity of chromatin
remodeling effectors, including transient recruitment of Brahma into RB/HDAC1 mega complexes, stable
association of RB with chromatin, formation of yH2AX DNA damage foci and global heterochromatization.
These chromatin changes coincided with expression of typical markers of senescence. Based on these
findings we hypothesize that epigenetic changes in genome maintenance lead to cellular and organismal
aging. Specifically, we propose to:
Aim 1: A) To determine whether the Brm1-associated chromatin remodeling activity is required for the
assembly of senescent-associated heterochromatic foci (SAHF) and RB-induced cellular senescence in
human melanocytes. This hypothesis will be tested using viral expression systems in primary cultures,
functional cell-based assays including an HDAC1-inducible system and chromatin-based assays. B) Define
senescent-dependent changes in the composition of Brm1/RB complexes. We will use HPLC-based, size
exclusion fractionation, immuno-isolation of complexes by HPLC fractionation, GST-pull-downs and Mass
Spectrometry. C) Determine whether a "conserved core" of chromatin remodeling complexes exists in livers
from old animals.
Aim 2: To define molecular links between epigenetic changes that precede senescence and the DNA
damage response. We will determine whether phosphorylation of H2AX and/or methylation of specific
Histone H3 residues are indicative of a "DNA response" triggered by chromatin remodeling.
Together, the studies included in this proposal are aimed at unraveling the role of sequential and cooperative
functions of histone modifying proteins in cellular senescence and tissue aging. If successful, our studies will
help define a "histone code for cellular aging"; and consequently open new avenues for interventions that
target the human epigenome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NAFLD: Mechanisms and Treatments
-
批准号:8828491
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2015
-
负责人:Nikolai A. Timchenko
-
依托单位:
Role of Age in Liver Cancer
-
批准号:8854542
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2014
-
负责人:Nikolai A. Timchenko
-
依托单位:
Role of Age in Liver Cancer
-
批准号:8923168
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2014
-
负责人:Nikolai A. Timchenko
-
依托单位:
Role of Age in Liver Cancer
-
批准号:8312480
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2011
-
负责人:Nikolai A. Timchenko
-
依托单位:
Testing the role of chromatin in healthspan
-
批准号:8116898
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2011
-
负责人:Nikolai A. Timchenko
-
依托单位:
Role of Age in Liver Cancer
-
批准号:8110910
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2011
-
负责人:Nikolai A. Timchenko
-
依托单位:
Testing the role of chromatin in healthspan
-
批准号:8249375
-
项目类别:
-
资助金额:$16.04万
-
财政年份:2011
-
负责人:Nikolai A. Timchenko
-
依托单位:
Role of Age in Liver Cancer
-
批准号:8460945
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2011
-
负责人:Nikolai A. Timchenko
-
依托单位:
Epigenetic Regulation of Cell and Tissue Aging
-
批准号:7919013
-
项目类别:
-
资助金额:$17.96万
-
财政年份:2009
-
负责人:Nikolai A. Timchenko
-
依托单位:
Epigenetic Regulation of Cell and Tissue Aging
-
批准号:8119610
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2007
-
负责人:Nikolai A. Timchenko
-
依托单位:
Epigenetic Regulation of Cell and Tissue Aging
-
批准号:8726047
-
项目类别:
-
资助金额:$8.69万
-
财政年份:2007
-
负责人:Nikolai A. Timchenko
-
依托单位:
C/EBP alpha in Aging Liver
-
批准号:7115249
-
项目类别:
-
资助金额:$25.63万
-
财政年份:2005
-
负责人:Nikolai A. Timchenko
-
依托单位:
C/EBP alpha in Aging Liver
-
批准号:7482273
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2005
-
负责人:Nikolai A. Timchenko
-
依托单位:
C/EBP alpha in Aging Liver
-
批准号:6965338
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2005
-
负责人:Nikolai A. Timchenko
-
依托单位:
C/EBP alpha in Aging Liver
-
批准号:7266857
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2005
-
负责人:Nikolai A. Timchenko
-
依托单位:
C/EBP alpha in Aging Liver
-
批准号:7672460
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2005
-
负责人:Nikolai A. Timchenko
-
依托单位:
Regulation of cell growth by RNA binding proteins
-
批准号:7667813
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2003
-
负责人:Nikolai A. Timchenko
-
依托单位:
Regulation of cell growth by RNA binding proteins
-
批准号:7825340
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2003
-
负责人:Nikolai A. Timchenko
-
依托单位:
Regulation of Cell Growth by RNA Binding Proteins
-
批准号:6719627
-
项目类别:
-
资助金额:$26.79万
-
财政年份:2003
-
负责人:Nikolai A. Timchenko
-
依托单位:
Regulation of cell growth by RNA binding proteins
-
批准号:7524879
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2003
-
负责人:Nikolai A. Timchenko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: